EVOLUS, INC.

EOLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017
Revenue $0
Cost of Revenue $0
Gross Profit $0
Gross Margin
Operating Expenses
Research & Development $6.5M $6.7M
SG&A Expense $29.1M $4.8M
Operating Income $-46.1M $-11.7M
Operating Margin
Interest Expense $863.0K $5.0K
Pretax Income $-46.8M $-11.7M
Income Tax Expense $65.0K $-7.3M
Net Income $-46.9M $-4.5M
Net Margin
EPS (Basic) $-1.92 $-0.27
EPS (Diluted) $-1.92 $-0.27
Shares Outstanding (Basic) 27.3M 16.5M
Shares Outstanding (Diluted) 27.3M 16.5M
Dividends Per Share
← Newer Page 2 of 2 Older →